• 53
  • 7
  • 收藏

France cancels order for Merck's COVID-19 antiviral drug

Reuters2021-12-22

PARIS, Dec 22 (Reuters) - France has cancelled its order for Merck & Co's COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the end...

网页链接

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论7

  • windz123
    ·2021-12-23
    ok
    回复
    举报
  • kamy
    ·2021-12-23
    Gg
    回复
    举报
  • NeedMoneyPls
    ·2021-12-22
    Wow I thought they said it's much more effective than Pfizer and Moderna. Wonder issit they got paid off so the other two can continue to earn money. 
    回复
    举报
    收起
    • 慢的老人
      I don't think any amount of money would be worth the reputational damage Merck would incur. It is more likely that Merck's drug was not tested extensively enough until now.
      2021-12-23
      回复
      举报
    • halforc
      ok
      2021-12-22
      回复
      举报
  • BillyWu
    ·2021-12-22
    Omg
    回复
    举报
  • StansenSG
    ·2021-12-22
    L
    回复
    举报
    收起
  • Lollmaorofl
    ·2021-12-22
    Ah shit definitely not the best news for Merck...
    回复
    举报
  • YewKhoon
    ·2021-12-22
    Like pls 
    回复
    举报
    收起
    • xxbbew
      Ok
      2021-12-22
      回复
      举报
 
 
 
 

热议股票

 
 
 
 
 

7x24